Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Mangoceuticals Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE
Ticker
Exchange
SIC #
Website
Latest Ticker
MGRX
Nasdaq
8011
https://www.mangorx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Mangoceuticals Inc
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
- Apr 25th, 2024 12:30 pm
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
- Apr 12th, 2024 12:45 pm
This Mangoceuticals Insider Increased Their Holding In The Last Year
- Apr 10th, 2024 11:02 am
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
- Mar 12th, 2024 1:00 pm
MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth
- Feb 20th, 2024 2:00 pm
MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY
- Feb 13th, 2024 1:00 pm
MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS
- Feb 6th, 2024 2:00 pm
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
- Feb 5th, 2024 1:50 pm
MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11
- Jan 19th, 2024 1:00 pm
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering
- Dec 15th, 2023 3:39 pm
MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT
- Dec 13th, 2023 12:30 pm
Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America
- Dec 6th, 2023 1:00 pm
Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider
- Nov 29th, 2023 1:30 pm
Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx
- Nov 16th, 2023 1:30 pm
Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men’s Health Awareness Month
- Nov 2nd, 2023 1:15 pm
Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls
- Oct 26th, 2023 11:30 am
Mangoceuticals, Inc. Provides Update to Shareholders on Q3 Achievements and Guidance on Year End and Near-Term Initiatives
- Oct 19th, 2023 1:00 pm
Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business
- Oct 13th, 2023 1:40 pm
New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network
- Oct 13th, 2023 1:12 pm
Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth
- Oct 12th, 2023 1:15 pm
Scroll